Defunct Company
Total Trials
12
As Lead Sponsor
9
As Collaborator
3
Total Enrollment
1,239
NCT00909181
Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
Phase: Phase 3
Role: Lead Sponsor
Start: Mar 31, 2009
Completion: Nov 30, 2010
NCT01737944
Exposure Study Comparing 3 Routes of Methotrexate (MTX) Administration
Phase: Phase 1/2
Start: Jan 31, 2011
Completion: Jun 30, 2011
NCT01618955
Actual Human Use of Methotrexate (MTX) Subcutaneously Administered Via the VIBEX™ MTX Auto-Injector Device
Phase: Phase 2
Start: May 31, 2012
Completion: Jul 31, 2012
NCT01618968
Comparison of Methotrexate (MTX) and the VIBEX™ MTX Device
Completion: Aug 31, 2012
NCT01887418
Pharmacokinetic Study of Testosterone Enanthate
Start: Sep 30, 2013
Completion: Jan 31, 2014
NCT02159469
Subcutaneous Testosterone Replacement Efficacy and Safety in Adult Men Diagnosed With Hypogonadism
Start: Jul 31, 2014
Completion: Nov 30, 2015
NCT02233751
Pharmacokinetic Study of Subcutaneous Testosterone Enanthate
Phase: Phase 1
Start: Sep 30, 2014
Completion: Oct 31, 2014
NCT02504541
Subcutaneous Testosterone Enanthate Safety in Adult Men Diagnosed With Hypogonadism
Start: Jul 31, 2015
Completion: Jun 30, 2016
NCT02777242
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
Start: Jun 30, 2016
Completion: Aug 31, 2016
NCT03194828
Real-time Glaucoma Medication Adherence
Phase: N/A
Role: Collaborator
Start: May 8, 2017
Completion: Jul 15, 2018
NCT04879589
Phase 1 Study of ATRS-2002 in Healthy Male Adults
Start: Sep 1, 2022
Completion: Apr 20, 2023
NCT04601233
Testosterone Treatment for Erectile Dysfunction and Multiple Sclerosis
Phase: Phase 4
Start: Jun 30, 2026
Completion: Dec 31, 2026